Grants and Contributions:
Title:
Atlas: Point-of-Care COVID-19 Diagnostic ELISA Powered by Digital Microfluidics
Agreement Number:
962045
Agreement Value:
$2,000,000.00
Agreement Date:
Jan 4, 2021 - Jan 3, 2022
Description:
The Public Health Agency of Canada (PHAC) and National Research Council (NRC) are seeking a solution that will diagnose individuals affected by COVID-19 within 3 days of the start of their symptoms using a sample, other than a nasopharyngeal swab, with a rapid single-use home testing kit analogous to a home pregnancy test.
Organization:
National Research Council Canada
Expected Results:
Grow Canadian companies through direct funding to support early stage, pre-commercial research and development, late stage prototypes, and to accelerate commercialization.
Location:
Kitchener, Ontario, CA N2G 2K4
Reference Number:
172-2020-2021-Q4 - 962045
Agreement Type:
Grant
Report Type:
Grants and Contributions
Recipient Business Number:
745547281
Recipient Type:
For-profit organization
Recipient's Operating Name:
Nicoya Lifesciences Inc.
Recipient's Legal Name:
Nicoya Lifesciences Inc.
Research Organization:
National Research Council Canada/Conseil national de recherches Canada
Federal Riding Name:
Kitchener Centre
Federal Riding Number:
35045
Program:
Innovative Solutions Canada
Program Purpose:
Fuel the development and adoption of technological innovation in Canada
Coverage:
• Support the scale up and growth of Canada's innovators and entrepreneurs by having the federal government act as a first customer. • Stimuler l'expansion et la croissance des innovateurs et entrepreneurs canadiens en faisant du gouvernement fédéral le premier client des innovations canadiennes.
NAICS Code:
54171